This project focuses on the sequence analysis, structure-function relationships, and post-translational modifications of proteins. By an improved method for purification of the anti-HIV protein MAP 30 from Momordica charantia seeds, an additional component designated as MAP 30II was isolated and found to have ribosome-inactivating activity and topoisomerase-like activity, and to inhibit HIV-1 infection as well as replication. Neither cytotoxicity to the host cells nor toxicity in mice were detected. MAP 30II consists of 252 or 253 amino acid residues in a single chain without intra-chain disulfide linkages. It has Asp as N- terminus and Gly or Asp as C-terminus, and is homologous in sequence with the abortifacient, alpha-trichosanthin. The primary amino acid sequence and the phosphorylation site of a heat- and acid-labile protein kinase substrate from rat brain were also determined. The amino acid sequence was identical to the 78-residue sequence deduced from rat brain RC3 cDNA and is homologous to bovine neurogranin. Analyses of 32P-labeled tryptic and BrCN cleaved peptides showed that only one residue (Ser36) was phosphorylated. The sequence can be divided into three segments with the following features: (1) a highly acidic region at residues 1-25; (2) the PKC phosphorylation site and calmodulin- binding domain in the middle; and (3) a collagen chain-like structure in the last 25 residues. Based on these features, a specific PKC substrate peptide (AAAKIQASFRGHMARKKIK-amide) was designed for assay of PKC levels in tissues and cells.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
United States
Zip Code